Cargando…
Cemiplimab for cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427629/ https://www.ncbi.nlm.nih.gov/pubmed/36110176 http://dx.doi.org/10.18773/austprescr.2022.050 |
Ejemplares similares
-
Durvalumab for urothelial carcinoma, non-small cell lung cancer
Publicado: (2019) -
Brigatinib for non-small cell lung cancer
Publicado: (2020) -
Lorlatinib for non-small cell lung cancer
Publicado: (2020) -
Entrectinib for non-small cell lung cancer and solid tumours
Publicado: (2020) -
Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside
por: Goodman, D.T.
Publicado: (2022)